Giant cell arteritis with polymyalgia rheumatica digital illustration

Giant cell arteritis with polymyalgia rheumatica Save


ICD-10 code: M31.5

Disease category: M31.5: Giant cell arteritis with polymyalgia rheumatica

Giant Cell Arteritis with Polymyalgia Rheumatica: Understanding the Connection

Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two closely related inflammatory conditions that often occur together. Let's explore the connection between these two conditions and gain a better understanding of their impact on individuals.

GCA primarily affects the medium and large arteries in the head, particularly the temporal arteries. It is characterized by inflammation and swelling, leading to symptoms such as severe headaches, scalp tenderness, jaw pain, and vision problems. On the other hand, PMR mainly affects the muscles and joints, causing stiffness, pain, and limited mobility, typically in the shoulders, hips, and neck.

While GCA and PMR are distinct conditions, they often coexist and share some similarities. In fact, studies suggest that up to 50% of GCA patients also develop PMR. This association is thought to be due to similar underlying mechanisms and genetic factors.

Key features of GCA with PMR:

  1. Age: GCA with PMR primarily affects individuals over the age of 50, with a higher incidence in women.
  2. Systemic inflammation: Both conditions involve systemic inflammation, which can lead to fatigue, weight loss, fever, and an overall feeling of malaise.
  3. Elevated inflammatory markers: Blood tests often reveal increased levels of markers like erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) in individuals with GCA and PMR.
  4. Response to corticosteroids: Both GCA and PMR typically respond well to corticosteroid treatment, which helps manage symptoms and reduce inflammation.

It's important to note that GCA with PMR can have serious implications if left untreated. GCA, in particular, can lead to vision loss or other complications if not diagnosed and managed promptly. Therefore, individuals experiencing symptoms associated with GCA or PMR should seek medical attention for appropriate diagnosis and treatment.

In conclusion, GCA with PMR is a complex combination of conditions characterized by inflammation in the arteries and muscles. Understanding the connection between these two conditions can help healthcare professionals provide accurate diagnoses and effective management strategies for affected individuals.

Treatment of Giant cell arteritis with polymyalgia rheumatica:

Treatment Options for Giant Cell Arteritis with Polymyalgia Rheumatica

Giant cell arteritis (GCA) with polymyalgia rheumatica (PMR) is a condition that affects the blood vessels, causing inflammation and pain in the muscles and joints. It primarily affects individuals over the age of 50 and can lead to serious complications if left untreated. Fortunately, there are several treatmen...

To see full information about treatment please Sign up or Log in